Relating to health benefit plan coverage of anxiety and pain management in connection with prescription contraceptive devices.

SB 1688 requires health insurance plans covering FDA-approved contraceptive devices to include coverage for evidence-based anxiety and pain management during insertion or removal. This includes prescription antianxiety medication, sedation, local anesthesia, topical anesthetics, and nerve blocks, with no cost-sharing (like deductibles or coinsurance) allowed for these services. The law applies only to plans issued or renewed on or after January 1, 2026, and affects insurers offering contraceptive coverage. It directly impacts individuals using prescription contraceptives and the health benefit plans providing their coverage.